Hormone Therapy Reduced Insulin Resistance in Healthy Postmenopausal Women

A new large-scale, meta-analysis, suggests hormone replacement therapy (HRT) can control insulin resistance in healthy, post-menopausal women. This finding could help guide the use of HRT, something that has long been controversial but could apparently have substantial benefits for certain patients.

Results of the meta-analysis, which included over 17 trials, were presented at the 2024 Annual Meeting of The Menopause Society last week. The presenter was Tanya Li of the Drexel University College of Medicine in Philadelphia.
LINK